title: Adriamycin versus BCG in superficial bladder cancer: a Southwest Oncology Group Study.
authors.affiliation: Department of Urology, West Virginia University, Morgantown.
authors.forename: D L
authors.initials: DL
authors.lastname: Lamm
authors.forename: J
authors.initials: J
authors.lastname: Crissmann
authors.forename: B
authors.initials: B
authors.lastname: Blumenstein
authors.forename: E D
authors.initials: ED
authors.lastname: Crawford
authors.forename: J
authors.initials: J
authors.lastname: Montie
authors.forename: P
authors.initials: P
authors.lastname: Scardino
authors.forename: H B
authors.initials: HB
authors.lastname: Grossman
authors.forename: T
authors.initials: T
authors.lastname: Stanisic
authors.forename: J
authors.initials: J
authors.lastname: Smith
authors.forename: J
authors.initials: J
authors.lastname: Sullivan
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001500:BCG Vaccine / Q000627:therapeutic use*; D002278:Carcinoma in Situ / Q000188:drug therapy* / Q000628:therapy; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy* / Q000628:therapy; D004317:Doxorubicin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D009364:Neoplasm Recurrence, Local; D009367:Neoplasm Staging; D011379:Prognosis; D011446:Prospective Studies; D011897:Random Allocation; D013997:Time Factors; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000628:therapy
chemical_list: D001500:BCG Vaccine; D004317:Doxorubicin